Annual TB Conference: The Union - NAR

The Annual Union-North America Region's (NAR) TB conference is organized by the BC Lung Association. We serve as Conference Secretariat and sit on the NAR Conference Executive Committee.  

Held in February every year, the 2020 will take place in Chicago. Conferences details will be posted by Fall 2019. (Read the NAR Charter)

Please email Dr. Menn Biagtan, VP Health Programs and Initiatives (biagtan@bc.lung.ca), should have questions regarding the 2020 conference. 

 

 2019 HIGHLIGHTS | 23rd ANNUAL CONFERENCE  Vancouver, Canada, February 21 to 23, 2019
  • 300 international participants from various disciplines
  • 128 abstracts submitted. 123 accepted for poster presentation (Download abstract book)
  • 6 abstracts were chosen for oral presentation
  • 14 delegates received travel grant support, 3 of which are based outside North America.  
  • 2019 George Comstock Lecture presenter: Dr. Eric Goosby, UN Special Envoy on Tuberculosis "Next steps following the UN High Level Meeting on TB"
  • 2019 Beyond TB Lecture presenter:  Dr. Patricia Daly, Chief Medical Health Officer and VP, Public Health, Vancouver Coastal Health "The Opioid Crisis"
  • 2019 Lifetime Achievement Award recipient: Dr. Andrew A. Vernon,  U.S. Centers for Disease Control and Prevention. 
  • Noteworthy 2019 conference features: 1) The post-graduate lab course facilitated by Dr. Max Salfinger, 2) The learning circle facilitated by indigenous leaders and elders
2019 CONFERENCE PRESENTATION SLIDES
FEBRUARY 20, 2019
 
Post-Graduate Course
 
DR. DAVID LEWINSOHN
Oregon Health & Science University
 
DR. CHARLES PELOQUIN
University of Florida
 
DR. JENNIER R. HONDA
National Jewish Health
 
Population Genomics of the M. tuberculosis Complex - Dr. Sebastien Gagneux, Swiss Tropical and Public Health Institute
 
FEBRUARY 21, 2019
 
Stop TB
TB Elimination among the Inuit of Canada - President Natan Obed, Inuit Tapiriit Kanatami
Can We End Tuberculosis? - Dr. Jennifer Flood, California Department of Public Health
 
Nursing-Sponsored Session
Engaging a Nunavut Community to Address Tuberculosis - Ms. Mishael Gordon, Government of Nunavut and Mrs. Daisy Arnaquq, Municipality of Qikiqtarjuaq
 
FEBRUARY 22, 2019
 
Top 10 Updates in TB from 2018
TB Drugs: PK Update - Dr. Kelly Dooley, Johns Hopkins School of Medicine
TB Laboratory Update - Dr. Max Salfinger, University of South Florida
 
The Beyond TB Lecture
The Opioid Overdose Crisis: Role of the TB Physician - Dr. Patricia Daly, Vancouver Coastal Health
 
LTBI Treatment in Special Populations
LTBI Treatment in Pregnancy - Dr. Sylvia LaCourse, University of Washington
LTBI Treatment in non–HIV Immunosuppressed Patients - Dr. Richard Zuckerman, Dartmouth-Hitchcock/Dartmouth Geisel School of Medicine
Patient-Centered Approaches to LTBI Treatment for “Challenging” Patients - Dr. Courtney Yuen, Brigham and Women’s Hospital/Harvard Medical School
 
FEBRUARY 23, 2019
 
TB Drug Development and Regimens: A Clinical Trials Update
New Drugs and Regimens for Treatment of Drug-Sensitive TB (DS-TB) - Dr. Patrick Phillips, University of California, San Francisco
New Drugs and Regimens for Drug-Resistant TB - Dr. C. Robert Horsburgh, Jr., Boston University School of Public Health
ACTG TB Transformative Science Group Protocol Updates - Dr. Kelly Dooley, Johns Hopkins School of Medicine
 
TB and Human Rights: The Pathways for Health Equity for Aboriginal Peoples
Two Row Wampum, Human Rights and the Elimination of Tuberculosis from High-Incidence Indigenous Communities - Dr. Richard Long, University of Alberta; Courtney Heffernan; Melissa Cardinal-Grant; Barbara George; Diane Janvier
 
The Latest in TB Prevention
TB Vaccines: The Glass Half Full - Dr. David Lewinsohn, Oregon Health & Science University
LTBI Treatment Trials: Where are We and What’s Next - Dr. Bob Belknap, Denver Public Health
 
 
PAST MEETING ARCHIVES

Page Last Updated: 03/05/2019